Patent details

EP3495495 Title: DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORS

Basic Information

Publication number:
EP3495495
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP181922360
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORS
French Title of Invention:
MARQUEURS DIAGNOSTIQUES POUR TRAITER DES TROUBLES DE PROLIFÉRATION CELLULAIRE AVEC DES INHIBITEURS DE LA TÉLOMÉRASE
German Title of Invention:
DIAGNOSTISCHE MARKER ZUR BEHANDLUNG VON ZELLPROLIFERATIVEN ERKRANKUNGEN MIT TELOMERASEINHIBITOREN
SPC Number:

Dates

Filing date:
27/11/2013
Grant date:
23/12/2020
EP Publication Date:
12/06/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/12/2020
EP B1 Publication Date:
23/12/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/11/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/12/2020
 
 

Name:
Geron Corporation
Address:
919 E. Hillsdale Blvd., Foster City, CA 94404, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
25/01/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
BURINGTON, Bart
Address:
United States (US)

2

Name:
WANG, Hui
Address:
United States (US)

3

Name:
ENG, Kevin
Address:
United States (US)

4

Name:
BASSETT, Ekaterina
Address:
United States (US)

Priority

1

Priority Number:
201261732263 P
Priority Date:
30/11/2012
Priority Country:
United States (US)

2

Priority Number:
201361780851 P
Priority Date:
13/03/2013
Priority Country:
United States (US)

3

Priority Number:
201313802035
Priority Date:
13/03/2013
Priority Country:
United States (US)

4

Priority Number:
201361798478 P
Priority Date:
15/03/2013
Priority Country:
United States (US)

5

Priority Number:
201361809228 P
Priority Date:
05/04/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/7125; A61K 45/06; A61P 1/04; A61P 1/16; A61P 11/00; A61P 13/10; A61P 15/00; A61P 21/00; A61P 25/00; A61P 35/00; A61P 35/02; A61P 43/00; G01N 33/533; G01N 33/574; C12Q 1/6886;

Publication

European Patent Bulletin

1

Issue number:
202052
Publication date:
23/12/2020
Description:
Grant (B1)

2

Issue number:
202103
Publication date:
20/01/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/11/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/11/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
25/01/2021 Power Of Attorney 1
29/01/2021 Outgoing Correspondence 1